Navigation Links
Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies

muscle mass and strength is expected to produce a major clinical benefit across this broad range of serious medical conditions in which there are currently no safe and effective therapies that selectively increase skeletal muscle mass and strength.

About Acceleron Pharma
Acceleron is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of bone, muscle, fat and the vasculature to treat musculoskeletal, metabolic and cancer-related diseases. Acceleron¹s scientific approach takes advantage of its unique insight on the regenerative powers of two protein families: the Growth and Differentiation Factor (GDF) and Bone Morphogenetic Protein (BMP) families. The company¹s lead program is an anabolic bone agent being developed to reverse bone loss in diseases such as osteoporosis and cancer. Additionally, the company is advancing several preclinical programs that increase muscle mass, control angiogenesis and inhibit fat accumulation. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company¹s internal GMP manufacturing capability to rapidly and efficiently advance its therapeutic programs. The investors in Acceleron are Advanced Technology Ventures, Flagship Ventures, OrbiMed Advisors, Polaris Ventures, Sutter Hill Ventures and Venrock.

Contact: Steven Ertel, Vice President, Business Development, Acceleron Pharma, tel: 617-520-1334 and Paul Kidwell (Media) Suda Communications, tel: 617-296-3854 Paul Kidwell 617.296.3854: Office 617.680.1088: Mobile


'"/>




Page: 1 2 3

Related medicine technology :

1. Acceleron Pharmas ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
2. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
3. Rapid HIV Testing Increases Possibility of Treatment
4. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
5. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
6. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
7. Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
8. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
9. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
10. Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
11. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Post Your Comments:
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... England , August 20, 2014 ... be Conducted in the US  KalVista Pharmaceuticals ... macular edema (DME), today announces that it has begun ... novel plasma kallikrein inhibitor, KVD001, for the treatment of ... Sun of the Beetham Eye Institute, Joslin Diabetes Center; ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... 2011 Insmed Incorporated (Nasdaq: INSM ), a ... call on Thursday, March 10th, 2011, at 8:30 AM EST, ... year-end 2010.  Insmed intends to issue its quarterly and year-end ... 10th. To participate in the live conference ...
... 23, 2011 Reportlinker.com announces that a new ... Global Fetal Monitors Industry ... report analyzes the worldwide markets for Fetal Monitors ... Antepartum Monitors, and Intrapartum Monitors. The report provides ...
Cached Medicine Technology:Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call 2
(Date:8/20/2014)... August 21, 2014 On September 7th, 2014 ... MS organization connects people living with MS with people who ... dollars and are 85% of the way to their goal. ... registration begins at 11:30 and the walk starts at ... available to answer question about chiropractic care and how it ...
(Date:8/20/2014)... Medical Alert Systems, http://www.medicalalert-systems.com/ , a ... of the most popular medical alert devices including Medical ... it is now offering special deals and discounts on ... a fixed income but would like to purchase some ... welcome news. , As a company spokesperson for the ...
(Date:8/20/2014)... UWDress.com, the distinguished wedding dress manufacturer and retailer, has ... for girls . According to the company’s marketing specialist, ... experienced specialists. Now, they are provided with discounted prices, ... items come in various styles: A-line scalloped edge gowns, ... backless gowns and so on. It is working hard ...
(Date:8/20/2014)... 2014 Park Avenue Dental, a leading ... Sherman, a top graduate of the University of Detroit ... of its website through an ultra-informative blog focused on ... of parkavenuedentalfl.com, the blog page is chock full of ... material, instead concentrating on important dental care tips ...
(Date:8/20/2014)... Locating rates for insurance packages will now be an ... new source of term life insurance providers has been added ... 50 states at http://quotespros.com/life-insurance.html . , The database ... available for the public to find out the exact annual ... quotations that are available are good through the rest of ...
Breaking Medicine News(10 mins):Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 2Health News:Medical Alert Systems Website Now Offering Special Prices on the Popular Medical Guardian Product 3Health News:Cheap Birthday Party Dresses for Girls Now Available at UWDress.com 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 3Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2
... of licorice may offer a new approach to ... of other preventive therapies, Vanderbilt University Medical Center ... in the Journal of Clinical Investigation , ... show that inhibiting the enzyme 11β-hydroxysteroid dehydrogenase type ...
... 23 Select Medical Corporation ("Select") today announced results ... 2008.For the fourth quarter ended December 31, 2008, net ... $518.0 million for the same quarter, prior year. ... to $41.7 million for the same quarter, prior year. ...
... Challenges Common Medical PracticePHILADELPHIA, March 23 For ... visually examined newborn babies for the yellowish skin ... jaundice carried a greater risk of illness.The yellowness ... child that develops high levels of bilirubin has ...
... was diagnosed at young age , , MONDAY, March 23 (HealthDay ... clots in the veins may be more than twice as ... condition, Dutch researchers report. , This kind of clot, known ... can break off and travel to the lungs. , The ...
... benefit seen with tightest control of risk factors, researchers ... tightest control of the major risk factors for heart ... trouble, a new study shows. , And so the ... and LDL cholesterol might need to be tightened even ...
... CREEK, Mich., March 23 Diplomat Specialty Pharmacy ... Hormone disease management program. Denise Piro, RN has joined ... to lead the national expansion of Diplomat,s Growth Hormone ... President of Sales and Marketing."Denise offers Diplomat the expertise ...
Cached Medicine News:Health News:Licorice compound offers new cancer prevention strategy 2Health News:Licorice compound offers new cancer prevention strategy 3Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 2Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 3Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 4Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 5Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 6Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 7Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 8Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 9Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 10Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 11Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 12Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 13Health News:Don't Rely on Jaundiced Eye for Assessing Newborns 2Health News:Don't Rely on Jaundiced Eye for Assessing Newborns 3Health News:Don't Rely on Jaundiced Eye for Assessing Newborns 4Health News:Family History Plays Key Role in Blood Clot Risk 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 3Health News:Diplomat Specialty Pharmacy Expands National Growth Hormone Patient Care Program - Hires Denise Piro, RN, BSN 2
... yet, the all-new Assure Pro Blood Glucose ... growing demands of the Long-Term Care profession. ... backlighting, and strip release offer better convenience, ... insert the test strip in the convenient ...
... For practices performing routine Holter,monitoring, ... QuickStep Wizard provides a,practical, no-nonsense ... managed health care,environment. This highly ... in a variety,of configurations at ...
... The Vision5L ... high-quality 5- or ... with a signal ... transfer using a ...
... II features a diagnostic interpretation,option ... Glasgow,(UG) algorithm. Unlike competitive products,which ... the UG,algorithm bases its analysis ... age, race, medication,and classification., Plus ...
Medicine Products: